Publications

5891 Results

A phase III randomized trial of anastrozole versus anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;D Lew;D Hayes;J Gralow;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abst. S1-1;oral presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0226

SWOG S0927: A randomized doubled blind placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor (AI)-induced musculoskeletal pain in women with early stage breast cancer

Authors
D Hershman;J Unger;K Crew;C Moinpour;L Minasian;L Hansen;D Lew;K Kaberle;J Wade;F Meyskens
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract OT2-07-02 (poster);
Year
2011
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927

A randomized phase III clinical trial of standard adjuvant endocrine therapy in patients (pts) with 1-3 positive nodes, hormone receptor (HR)-positive and HER-2negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
A Gonzalez-Angulo;W Barlow;J Gralow;F Meric-Bernstam;D Hayes;C Moinpour;S Ramsey;A Schott;D Sparks;K Albain;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract # OT1-03-01;poster presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation [PMID21680797;PMC3156042]

Authors
M Fang;B Storer;E Estey;M Othus;L Zhang;B Sandmaier;F Appelbaum
Journal / Conference
Blood 118(6):1490-1494
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9126, SWOG-9333, SWOG-9500

Cytarabine dose for acute myeloid leukemia. (Letter to the Editor) [PMID21631340]

Authors
B Medeiros;M Othus;F Appelbaum
Journal / Conference
New England Journal of Medicine 364(11):2167-2168
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

A phase III randomized intergroup trial (SWOG S0016) of CHOP chemotherapy plus rituximab vs. CHOP chemotherapy plus iodine-131 for the treatment of newly diagnosed follicular non- hodgkin's lymphoma

Authors
O Press;J Unger;L Rimsza;J Friedberg;M Leblanc;M Czuczman;M Kaminski;R Braziel;D Maloney;B Cheson;TP Miller;RI Fisher
Journal / Conference
Blood 118:abstract 98; American Society of Hematology Annual Meeting, oral
Year
2011
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Prognostic significance of FLT3 and NPM1 mutations in adults of age 18-60 with de novo acute myeloid leukemia (AML): a study by FHCRC and SWOG

Authors
EL Pogosova-Agadjanyan;K Kopecky;S Petersdorf;H Erba;RM Stone;S Mehinchi;TJ Nevill;J Radich;L Stenke;M Slovak;RK Stuart;M Tallman;C Willman;A Brumbaugh;M Cronk;C Cummings;J Engel;R Mortensen;A Suchanek;F Appelbaum;D Stirewalt
Journal / Conference
Blood 118(21):abst 2520; American Society of Hematology Annual Meeting, poster presentation;
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
S0106

Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): analysis of SWOG trial S0115

Authors
V Sanchorawala;A Hoering;DC Seldin;KT Finn;SA Fennessey;B Mattar;HF Safah;LA Holmberg;RM Dean;RZ Orlowski;B Barlogie
Journal / Conference
Blood 118(21):abstact 2004; American Society of Hematology, poster;
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
S0115

Response to high dose cytarabine (HIDAC) as first salvage for relapsed acute lymphocytic leukemia is not affected by prior exposure to HIDAC

Authors
A Advani;H Gundacker;N Nyatanga;PJ Rosen;M Sekeres;M Kalaycio;R Sobecks;E Copelan;F Appelbaum
Journal / Conference
Blood 118(21):abstract 2594; American Society of Hematology, poster;
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9030

KIT mutations are very uncommon among elderly AML patients: a SWOG report

Authors
F Ostronoff;M Othus;PA Ho;S Petersdorf;JE Anderson;JE Godwin;CL Willman;JP Radich;F Appelbaum;D Stirewalt;S Meshinchi
Journal / Conference
Blood 118(21):abstract 2510; American Society of Hematology (poster presentation);
Year
2011
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031, SWOG-9333